Diasorin
DiaSorin Ireland (formerly Biotrin International) has a history of developing niche Immuno Assays, some of which became best-in-class worldwide from both a quality and commercial standpoint.
DiaSorin Ireland's core competencies lie in Product Development, Regulatory compliance, high quality and reliable Manufacturing. These skills are currently being applied to Molecular Diagnostic Product Development and Manufacturing.
Financial Data
-
31st Dec 18 Source: CRO
- €20 million turnover
-
€32.5 million
profit - 52 employees
-
31st Dec 17 Source: CRO
- €18.7 million turnover
-
-€4.6 million
profit - 69 employees
- 3 more years available »
Ranking
By Turnover
(€20 million)- 893rd in Top Companies
- 97th in Health
By Employees
(52)- 829th in Top Companies
- 92nd in Health
- 52
- €20 million
Employees
- Colm Healy Vice President}
Latest News
- Mar 28 Retail landlords worried rents will dry up during Covid-19 crisis
- Mar 27 ECB orders banks to freeze dividends and share buybacks
- Mar 27 Mobile, broadband suppliers to be given extra radio spectrum
- Mar 27 Volkswagen burning through €2bn in cash per week
- Mar 27 Tui secures €1.8bn loan to navigate coronavirus crisis